JP2016047828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016047828A5 JP2016047828A5 JP2015201433A JP2015201433A JP2016047828A5 JP 2016047828 A5 JP2016047828 A5 JP 2016047828A5 JP 2015201433 A JP2015201433 A JP 2015201433A JP 2015201433 A JP2015201433 A JP 2015201433A JP 2016047828 A5 JP2016047828 A5 JP 2016047828A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- animal
- seq
- aureus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 12
- 241001465754 Metazoa Species 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 210000004408 hybridoma Anatomy 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 102000015636 Oligopeptides Human genes 0.000 claims 2
- 108010038807 Oligopeptides Proteins 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 208000004396 mastitis Diseases 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17913309P | 2009-05-18 | 2009-05-18 | |
| US61/179,133 | 2009-05-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511263A Division JP5882892B2 (ja) | 2009-05-18 | 2010-05-18 | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016047828A JP2016047828A (ja) | 2016-04-07 |
| JP2016047828A5 true JP2016047828A5 (enExample) | 2016-05-26 |
Family
ID=42316060
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511263A Expired - Fee Related JP5882892B2 (ja) | 2009-05-18 | 2010-05-18 | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
| JP2015201433A Pending JP2016047828A (ja) | 2009-05-18 | 2015-10-09 | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511263A Expired - Fee Related JP5882892B2 (ja) | 2009-05-18 | 2010-05-18 | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8609102B2 (enExample) |
| EP (1) | EP2432804B1 (enExample) |
| JP (2) | JP5882892B2 (enExample) |
| CN (1) | CN102695724B (enExample) |
| AU (1) | AU2010251156C1 (enExample) |
| BR (1) | BRPI1010911A2 (enExample) |
| CA (1) | CA2761886A1 (enExample) |
| ES (1) | ES2537437T3 (enExample) |
| MX (1) | MX2011012248A (enExample) |
| PL (1) | PL2432804T3 (enExample) |
| PT (1) | PT2432804E (enExample) |
| RU (1) | RU2560415C2 (enExample) |
| WO (1) | WO2010133600A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5882892B2 (ja) * | 2009-05-18 | 2016-03-09 | ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクＪｕｌｉｕｓ Ｍａｘｉｍｉｌｉａｎｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｗｕｅｒｚｂｕｒｇ | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
| WO2013041707A1 (en) | 2011-09-23 | 2013-03-28 | Julius-Maximilians-Universität Würzburg | Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
| US9944694B2 (en) | 2013-12-13 | 2018-04-17 | Rijksuniversiteit Groningen | Antibodies against Staphylococcus aureus and uses therof |
| CN119176871A (zh) | 2018-07-24 | 2024-12-24 | 免疫医疗有限责任公司 | 抗金黄色葡萄球菌凝集因子a(clfa)的抗体 |
| KR102341805B1 (ko) * | 2019-11-27 | 2021-12-22 | 주식회사 하울바이오 | 황색포도상구균에 특이적으로 반응하는 항-IsaA G4 항체 및 이의 용도 |
| KR102341804B1 (ko) * | 2019-11-27 | 2021-12-22 | 주식회사 하울바이오 | 황색포도상구균을 억제하는 항-IsaA F10 항체 및 이의 용도 |
| US20230357373A1 (en) * | 2019-12-17 | 2023-11-09 | Mie University | Methods and compositions for evaluating and treating fibrosis |
| WO2022250205A1 (ko) * | 2021-05-25 | 2022-12-01 | 주식회사 하울바이오 | 항-IsaA F10 항체의 아토피 피부염 예방 및 개선 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4238806A1 (en) * | 1991-11-18 | 1993-05-27 | Dainabot Co | Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides |
| FR2746398B1 (fr) * | 1996-03-21 | 1998-04-30 | Bio Merieux | Anticorps specifique de staphylococcus aureaus, et utilisations |
| RU2144190C1 (ru) * | 1998-01-13 | 2000-01-10 | Катханов Али Муратович | Способ диагностики стафилококковой инфекции |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| GB0127983D0 (en) * | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
| KR20070104590A (ko) * | 2005-01-10 | 2007-10-26 | 나비 바이오파마슈티컬즈 | 스타필로코쿠스 아우레우스 감염을 치료하는 방법 |
| JP5882892B2 (ja) * | 2009-05-18 | 2016-03-09 | ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクＪｕｌｉｕｓ Ｍａｘｉｍｉｌｉａｎｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｗｕｅｒｚｂｕｒｇ | 黄色ブドウ球菌エピトープＩｓａＡまたはＩｓａＢに対する抗体またはそれらのフラグメント |
-
2010
- 2010-05-18 JP JP2012511263A patent/JP5882892B2/ja not_active Expired - Fee Related
- 2010-05-18 CN CN201080021810.5A patent/CN102695724B/zh not_active Expired - Fee Related
- 2010-05-18 BR BRPI1010911A patent/BRPI1010911A2/pt not_active IP Right Cessation
- 2010-05-18 PL PL10720416T patent/PL2432804T3/pl unknown
- 2010-05-18 WO PCT/EP2010/056827 patent/WO2010133600A1/en not_active Ceased
- 2010-05-18 RU RU2011146424/10A patent/RU2560415C2/ru not_active IP Right Cessation
- 2010-05-18 ES ES10720416.6T patent/ES2537437T3/es active Active
- 2010-05-18 AU AU2010251156A patent/AU2010251156C1/en not_active Ceased
- 2010-05-18 US US13/320,743 patent/US8609102B2/en not_active Expired - Fee Related
- 2010-05-18 PT PT107204166T patent/PT2432804E/pt unknown
- 2010-05-18 CA CA2761886A patent/CA2761886A1/en not_active Abandoned
- 2010-05-18 MX MX2011012248A patent/MX2011012248A/es active IP Right Grant
- 2010-05-18 EP EP10720416.6A patent/EP2432804B1/en not_active Not-in-force
-
2013
- 2013-11-12 US US14/077,927 patent/US9260511B2/en not_active Expired - Fee Related
-
2015
- 2015-10-09 JP JP2015201433A patent/JP2016047828A/ja active Pending
- 2015-12-30 US US14/984,958 patent/US9658230B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016047828A5 (enExample) | ||
| JP2019516394A5 (enExample) | ||
| TR201817932T4 (en) | ANTIBODIES THAT BIND STAPHYLOCOCCUS AUREUS ALPHA TOXIN SPECIFICALLY AND METHODS OF USE | |
| JP2017523786A5 (enExample) | ||
| RU2019132843A (ru) | Антитело против в7-н3, его антигенсвязывающий фрагмент и их медицинское применение | |
| JP2017518258A5 (enExample) | ||
| IL259940B2 (en) | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists | |
| RU2015121617A (ru) | Способы лечения заболеваний, ассоциированных с s. aureus | |
| JP2018193386A5 (enExample) | ||
| WO2020023644A3 (en) | Antibody directed against s. aureus clumping factor a (clfa) | |
| JP2017505125A5 (enExample) | ||
| JP2017530722A5 (enExample) | ||
| TR201809128T4 (tr) | Gram-pozitif bakterilere spesifik bağlanan bileşikler. | |
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| WO2016207304A8 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2018520334A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| JP2017510567A5 (enExample) | ||
| HRP20240975T1 (hr) | Protutijela specifična za cd3 i njihova upotreba | |
| RU2016107814A (ru) | Новое антитело к tslp-рецептору человека | |
| JP2021502984A5 (enExample) | ||
| RU2011146424A (ru) | Антитела или их фрагменты, направленные против эпитопа стафилококка золотистого (staphylococcus aureus) | |
| JP2015536951A5 (enExample) | ||
| RU2019134462A (ru) | Антитела, связывающиеся с steap-1 |